These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24837565)

  • 1. [Neuroimaging of Langerhans cell histiocytosis in the central nervous system of children].
    De La Hoz Polo M; Rebollo Polo M; Fons Estupiña C; Muchart López J; Cruz Martinez O
    Radiologia; 2015; 57(2):123-30. PubMed ID: 24837565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system disease in Langerhans cell histiocytosis.
    Grois NG; Favara BE; Mostbeck GH; Prayer D
    Hematol Oncol Clin North Am; 1998 Apr; 12(2):287-305. PubMed ID: 9561901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [MR-documented remission of pituitary stalk infiltration in patients with Langerhans cell histiocytosis following treatment with 2-chlorodeoxyadenosine].
    Vanícek J; Adam Z; Balsíková K; Krejcí M; Pour L; Szturz P; Zahradová L; Hájek R; Koukalová R; Rehák Z; Král Z; Mayer J
    Vnitr Lek; 2011 Oct; 57(10):871-5. PubMed ID: 22097697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Central diabetes insipidus in adult patients--the first sign of Langerhans cell histiocytosis and Erdheim-Chester disease. Three case studies and literature review].
    Adam Z; Balsíková K; Krejcí M; Pour L; Stĕpánková S; Svacina P; Hermanová M; Vanícek J; Krupa P; Stanícek J; Koukalová R; Neubauer J; Krivanová A; Mayer J; Hájek R
    Vnitr Lek; 2010 Feb; 56(2):138-48. PubMed ID: 20329585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine.
    Dhall G; Finlay JL; Dunkel IJ; Ettinger LJ; Kellie SJ; Allen JC; Egeler RM; Arceci RJ
    Pediatr Blood Cancer; 2008 Jan; 50(1):72-9. PubMed ID: 17455311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for the Prevention of Central Nervous System Complications in Patients with Langerhans Cell Histiocytosis: The Problem of Neurodegenerative Syndrome.
    Imashuku S; Arceci RJ
    Hematol Oncol Clin North Am; 2015 Oct; 29(5):875-93. PubMed ID: 26461148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Langerhans cell histiocytosis in adult patients--a disease with many faces. Experience of a centre and an overview of the disease symptoms].
    Adam Z; Pour L; Krejcí M; Neubauer J; Vanícek J; Vasků V; Hájek R
    Vnitr Lek; 2008 Nov; 54(11):1063-80. PubMed ID: 19069680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicoradiological Discrepancy in Multisystem Langerhans Cell Histiocytosis with Central Nervous System Involvement.
    Algahtani H; Shirah B; Bajunaid M; Subahi A; Al-Maghraby H
    Gulf J Oncolog; 2019 Sep; 1(31):72-77. PubMed ID: 31591994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain 18-FDG PET scan in central nervous system langerhans cell histiocytosis.
    Calming U; Bemstrand C; Mosskin M; Elander SS; Ingvar M; Henter JI
    J Pediatr; 2002 Sep; 141(3):435-40. PubMed ID: 12219070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management and Outcome of Patients With Langerhans Cell Histiocytosis and Single-Bone CNS-Risk Lesions: A Multi-Institutional Retrospective Study.
    Chellapandian D; Shaikh F; van den Bos C; Somers GR; Astigarraga I; Jubran R; Degar B; Carret AS; Mandel K; Belletrutti M; Dix D; Visser J; Abuhadra N; Chang T; Rollins B; Whitlock J; Weitzman S; Abla O
    Pediatr Blood Cancer; 2015 Dec; 62(12):2162-6. PubMed ID: 26179251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Langerhans Cell Histiocytosis of the Orbit: Spectrum of Disease and Risk of Central Nervous System Sequelae in Unifocal Cases.
    Esmaili N; Harris GJ
    Ophthalmic Plast Reconstr Surg; 2016; 32(1):28-34. PubMed ID: 25689784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Langerhans' cell histiocytosis and the nervous system.
    Burn DJ; Watson JD; Roddie M; Chu AC; Legg NJ; Frackowiak RS
    J Neurol; 1992 Jul; 239(6):345-50. PubMed ID: 1512612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system disease in Langerhans cell histiocytosis.
    Grois N; Tsunematsu Y; Barkovich AJ; Favara BE
    Br J Cancer Suppl; 1994 Sep; 23():S24-8. PubMed ID: 8075002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Langerhans cell histiocytosis: presentation and evolution of radiologic findings with clinical correlation.
    Meyer JS; Harty MP; Mahboubi S; Heyman S; Zimmerman RA; Womer RB; Dormans JP; D'Angio GJ
    Radiographics; 1995 Sep; 15(5):1135-46. PubMed ID: 7501855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary gland and bone involvement of Langerhans cell histiocytosis in a boy and brief review of the literature.
    Miao C; Zhang L; Sun M; Ma C
    Hell J Nucl Med; 2018; 21(2):148-150. PubMed ID: 30006648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine/cytosine arabinoside.
    Allen CE; Flores R; Rauch R; Dauser R; Murray JC; Puccetti D; Hsu DA; Sondel P; Hetherington M; Goldman S; McClain KL
    Pediatr Blood Cancer; 2010 Mar; 54(3):416-23. PubMed ID: 19908293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of multisystem Langerhans cell histiocytosis presenting as central diabetes insipidus.
    Nicholas PD; Garrahy I
    J Community Hosp Intern Med Perspect; 2019; 9(6):515-517. PubMed ID: 32002162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine changes in histiocytosis of the hypothalamic-pituitary axis.
    Toro Galván S; Planas Vilaseca A; Michalopoulou Alevras T; Torres Díaz A; Suárez Balaguer J; Villabona Artero C
    Endocrinol Nutr; 2015 Feb; 62(2):72-9. PubMed ID: 25434508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and treatment of Langerhans cell histiocytosis patients with central nervous system abnormalities: Current views and new vistas.
    Yeh EA; Greenberg J; Abla O; Longoni G; Diamond E; Hermiston M; Tran B; Rodriguez-Galindo C; Allen CE; McClain KL;
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28944988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose immunoglobulin (IVIG) may reduce the incidence of Langerhans cell histiocytosis (LCH)-associated central nervous system involvement.
    Imashuku S
    CNS Neurol Disord Drug Targets; 2009 Nov; 8(5):380-6. PubMed ID: 19702569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.